已收盘 05-22 16:00:00 美东时间
-0.100
-1.21%
今日重点评级关注:HC Wainwright & Co.:维持Artiva Biotherapeutics"买入"评级,目标价从15美元升至35美元;韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从36美元升至37美元
05-11 15:43
Stephens & Co. analyst Kyle Joseph maintains OppFi (NYSE:OPFI) with a Equal-Weight and raises the price target from $9 to $11.
05-08 20:48
OppFi (NYSE:OPFI) affirms FY2026 Adj EPS guidance from $1.76-$1.84 to $1.76-$1.84 vs $1.79 analyst estimate. Affirms FY2026 sales outlook from $650.000 million-$675.000 million to $650.000 million-$675.000 million vs
05-08 16:50
OppFi (NYSE:OPFI) reported quarterly earnings of $0.35 per share which beat the analyst consensus estimate of $0.33 by 6.06 percent. This is a 7.89 percent decrease over earnings of $0.38 per share from the same period
05-07 19:04
BISMARCK, N.D., April 29, 2026 /PRNewswire/ -- BNCCORP, INC. (OTCQX Markets: BNCC) ("BNCC") and its wholly owned subsidiary, BNC National Bank ("BNC") announced today it has signed a definit...
04-29 19:00
今日重点评级关注:Guggenheim:维持AtaiBeckley Inc."买入"评级,目标价从11美元升至16美元;RBC Capital:维持MeiraGTx Holdings"跑赢大市"评级,目标价从16美元升至24美元
04-20 11:33
Citizens analyst David M. Scharf maintains OppFi (NYSE:OPFI) with a Market Outperform and lowers the price target from $16 to $15.
04-17 21:24
Companies Reporting Before The Bell • Sprinklr (NYSE:CXM) is estimated to repor...
03-11 19:11
OppFi (NYSE:OPFI) is looking for FY2026 Adj EPS of $1.76-$1.84 vs $1.74 analyst estimate. sees sales of $650.000 million-$675.000 million vs $663.072 million analyst estimate.
03-11 19:03
OppFi (NYSE:OPFI) reported quarterly earnings of $0.30 per share which beat the analyst consensus estimate of $0.28 by 6.38 percent. This is a 30.43 percent increase over earnings of $0.23 per share from the same period
03-11 19:02